However, the analysis also showed that a given reduction in HbA1c was associated with a smaller relative increase in the incidence of hypoglycemia during treatment with insulin degludec compared to insulin glargine U100 (Philis-Tsimikas et al., 2020). The gene discussed is INS; the disease is Hypoglycemia.